Loteprednol/tobramycin, sold under the brand name Zylet, is a fixed-dose combination medication used for the treatment of inflammation of the eye. It is a combination of loteprednol, as the etabonate, a corticosteroid; and tobramycin, an aminoglycoside antibiotic. It is used as drops in the eye.
Loteprednol/tobramycin was approved for medical use in the United States in December 2004.
References
Further reading
- O'Gallagher M, Bunce C, Hingorani M, Larkin F, Tuft S, Dahlmann-Noor A (February 2017). "Topical treatments for blepharokeratoconjunctivitis in children". The Cochrane Database of Systematic Reviews. 2017 (2): CD011965. doi:10.1002/14651858.CD011965.pub2. PMC 6464561. PMID 28170093.
